Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin

Journal of Molecular Biology

Volumn 303, Issue 5, 2000, Pages 721-732

  Bhattacharya, Ananyo A ^a   Grüne, Tim ^a   Curry, Stephen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Crystal structure; Fatty acid binding; Human serum albumin; Lipid

Indexed keywords

ALBUMIN; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DRUG PROTEIN BINDING; FATTY ACID TRANSPORT; HUMAN; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE;

EID: 0034634370     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4158     Document Type: Article

References (57)

1. Medium chain fatty acid binding to human plasma albumin
2. Long chain fatty acid binding to human plasma albumin
3. Medium chain triglycerides and structured lipids
4. Medium-chain triglycerides: An update
5. Human serum albumin. Spectroscopic studies of binding and proximity relationships for fatty acids and bilirubin
6. Binding of the general anesthetics propofod and halothane to human serum albumin: High-resolution crystal structures
7. The fatty acid content and drug binding characteristics of commercial albumin preparations
8. Medium-chain fatty acids increase glucose production in normal and low birth weight newborns
9. Valproate and palmitate binding to human serum albumin: An hypothesis on obesity
10. Serum albumin: Structure and characterisation of its ligand binding sites
11. Crystallographic R-factor refinement by molecular dynamics
12. Structure of serum albumin
13. Preliminary crystallographic studies of four crystal forms of serum albumin
14. Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. I. The filling of individual fatty acid binding sites
15. Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. II. Electrostatic interactions in individual fatty acid binding sites
16. Effects of general anesthetics on the bacterial luciferase enzyme from Vibrio harveyi: An anesthetic target site with differential sensitivity
17. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites
18. Fatty acid binding to human serum albumin: New insights from crystallographic studies
19. Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: Relationship to drug lipophilicity and serum albumin binding
20. 19F-NMR study
21. An extensively modified version of MOLSCRIPT that includes greatly enhanced colouring capabilities
22. Mapping of general anaesthetic target sites provides a molecular basis for cutoff effects
23. The metabolism of albumin-bound C14-labeled unesterified fatty acids in normal human subjects
24. 13C NMR study
25. Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin
26. Atomic structure and chemistry of human serum albumin
27. X-ray and primary structure of horse serum albumin (Equus caballus) at 0.27-nm resolution
28. Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin
29. Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid
30. Localization of tolbutamide binding sites on human serum albumin using titration calorimetry and heteronuclear 2-D NMR
31. Secretory expression of human albumin domains in Saccharomyces cerevisiae and their binding of myristic acid and an acylated insulin analogue
32. Characterization of a small apolar anion binding site of human serum albumin
33. Structure and ligand binding properties of human serum albumin
34. Adipocyte lipid-binding protein complexed with arachidonic acid. Titration calorimetry and X-ray crystallographic studies
35. Acetylation of human serum albumin by p-nitrophenyl acetate
36. Raster3D - Photorealistic molecular graphics
37. Human serum albumin attenuates the activity of protease inhibitors towards wild-type and mutant human immunodeficiency virus
38. 13C NMR study
39. Kinetics of bilirubin binding to bovine serum albumin and the effects of palmitate
40. Location of long chain fatty acid-binding sites of bovine serum albumin by affinity labeling
41. Fragments of bovine serum albumin produced by limited proteolysis. Conformation and ligand binding
42. The binding of some long-chain fatty acid anions and alcohols by bovine serum albumin
43. Effect of drug combinations on bilirubin-albumin binding
44. The free fatty acids bound to human serum albumin
45. Non-enzymatic glycosylation of human serum albumin alters its conformation and function
46. Conjugated polyene fatty acids as fluorescent probes: Binding to bovine serum albumin
47. Human serum albumin. I. On the relationship of fatty acid and bilirubin sites and the nature of fatty acid allosteric effects - A monoanionic spin label study
48. The characterization of two specific drug binding sites on human serum albumin
49. Further characterization of specific drug binding sites on human serum albumin
50. Crystal structure of human serum albumin at 2.5 Å resolution
51. Characterization of the binding sites for dicarboxylic acids on bovine serum albumin
52. Binding of drugs by albumin and plasma protein
53. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy
54. Structural requirements for drug binding to site II on human serum albumin
55. β-Lactoglobulin binds palmitate within its central cavity
56. Structural studies on human muscle fatty acid binding protein at 1.4 Å resolution: Binding interactions with three C18 fatty acids